Amarin

Amarin Plays To Some Empty Seats at J.P. Morgan Confab
TheStreet.com
Wed, 01/9/13 - 08:00 am
Amarin
JPMHC 2013
Vascepa
13 Biotech Stock Predictions for 2013
TheStreet.com
Wed, 01/2/13 - 12:18 pm
Eisai
Sarepta
Arena Pharmaceuticals
Amarin
Gilead
Biomarin
Onyx
Medivation
Achillion
Incyte
Cell Therapeutics
Celgene
NPS Pharmaceuticals
Aegerion
Roche
Biogen Idec
Ariad Pharmaceuticals
Alexza
Navidea
Aveo
Is Amarin Still a Buy?
Motley Fool
Thu, 12/27/12 - 10:10 pm
Amarin
3 Drug Disappointments From 2012
Motley Fool
Wed, 12/26/12 - 09:33 pm
Zaltrap
Sanofi
Amarin
Vascepa
Qsymia
Arena Pharmaceuticals
The Good News Is This Can Only Go on for 5 Years
Motley Fool
Sat, 12/15/12 - 01:13 pm
Amarin
Vascepa
dyslipidemia
hypertriglyceridemia
4 Reasons Amarin Will Keep Tanking
Seeking Alpha
Fri, 12/14/12 - 11:52 am
Amarin
Amarin: 3 Things To Investigate (Further) For Vascepa
Seeking Alpha
Wed, 12/12/12 - 07:33 am
Amarin
Vascepa
3 Horrendous Health-Care Stocks This Week
Motley Fool
Sat, 12/8/12 - 11:02 am
Geron
Amarin
Acadia
Amarin's Stock Drops on Plan to Sell Heart Drug Vascepa Alone
Minyanville
Fri, 12/7/12 - 10:51 am
Vascepa
Amarin
The Price May Be Increasing For An Amarin Buyout
Seeking Alpha
Fri, 12/7/12 - 10:50 am
M&A
Vascepa
Amarin
Amarin Announces $100 Million Non-Equity Financing and Vascepa Sales Force Hiring While Continuing to Assess Strategic Alternatives
Yahoo
Thu, 12/6/12 - 05:31 pm
Amarin
Vascepa
financing
hirings
Discussing Amarin's Vascepa And GlaxoSmithKline's Lovaza With Omthera Pharma
Seeking Alpha
Tue, 12/4/12 - 11:54 am
Amarin
Vascepa
GSK
Lovaza
Omthera
Amarin's Big Initiation
Motley Fool
Sat, 12/1/12 - 09:54 am
Amarin
Celgene, NPS Pharmaceuticals, Amarin, J&J, Medivation Among Stocks to Watch in December
Minyanville
Fri, 11/30/12 - 04:28 pm
NPS Pharmaceuticals
Medivation
JNJ
Celgene
Amarin
Amarin Is Really Good At Delays, Drug Launches Not So Much
TheStreet.com
Thu, 11/29/12 - 10:42 am
Amarin
Vascepa
drug launches
Celgene
Sanofi
Teva and Amarin Aren't a Good Match
Motley Fool
Wed, 11/28/12 - 10:38 am
Amarin
Teva
M&A
A Must-See Look at Amarin's Best- and Worst-Case Scenarios
Motley Fool
Sun, 11/25/12 - 11:12 am
Amarin
First 90 Days of 2013 Are Live or Die For These Biotech Stocks
TheStreet.com
Mon, 11/19/12 - 02:00 pm
Oncothyreon
Celsion
Arena Pharmaceuticals
NuPathe
Hemispherx
Amarin
Biogen Idec
Gilead
Hyperion Therapeutics
Celgene
Raptor Pharmaceuticals
Dynavax
Zogenix
Impax Labs
Amarin announces notification of patent allowance related to Vascepa
Yahoo/Fly on the Wall
Mon, 11/19/12 - 11:06 am
Vascepa
patents
Amarin
Teva, AstraZeneca reportedly competing to court Irish drug company Amarin
Philadelphia Inquirer
Sat, 11/17/12 - 02:50 pm
Vascepa
Teva Pharmaceuticals
AstraZeneca
Amarin
M&A

Pages